InvestorsHub Logo
Followers 278
Posts 9122
Boards Moderated 1
Alias Born 08/07/2018

Re: None

Monday, 12/28/2020 9:19:32 AM

Monday, December 28, 2020 9:19:32 AM

Post# of 198211
12:28:2020 Just to think about entering this last week of the year
===
1. Read the Filing for June 30, 2020, there are a lot (shown below and we knew it ) but Over 1.15 Billion.. 1,150,000,000 SHARES increased in the O/S during the time from June 30,2020 to Nov 30,2020.
Also read through the past of assigned shares , there is one that shows multiple times and it can not be converted per the language until
a "Change of Control" happens. So Change of Control is overall good , but it also unlocks some apparent future conversion.
2. Some of those have obviously entered into the retail market during that time due to conversion just by looking at the number of shares that have traded in October, Nov and now Dec
3. Keep in mind, what you do not know : YOU DON't KNOW. We really only know the amount of shares... the filing tells us that, it does NOT tell us who got them or where they went. Just be cautious .
4. There are some other hurdles, Charles has to file the Sept 2020 first for many to read who those shares went to and for sure it has to go current into any next level area.
5. I do believe that they have licensing information and partners lined up , but once again we need to confirm that.
6. I do believe that since they list a second patent number with the new company (besides the original patent number Harry Z has) , that there is more to it and must involve Immunotech somehow. Harry Z specifically said that in his SEC filing 4/16/2020, which was there for a reason.
7. Lastly , with all the baggage that was here in O/S Shares and convertible notes plus risk, Charles C is way to smart and educated in their Market to get into something over his head. HE KNOWS and JOSEPH C plus GUARAV CHANDRA KNEW , that there is a VALUE Here by what they have communicated with , plus Dr. Ronald Moss coming over .. they KNEW ! and it has to involve BIG PHARMA, hence the drawn out Legal Process of Protecting the Patents and also making TWO NEW Companies just for licensing .
https://backend.otcmarkets.com/otcapi/company/financial-report/265788/content
8. Read back through the postings of ct808. Charles has to have completed getting the shares to offer the original Bioclonetics Shareholders . They have until 1/15 to pick their options.
--
From this weekend . TIME will tell.
Posted 12.26
*
12/26/20 : Factual items to think about that are currently out there , that need to be resolved. While I am always a "proponent" and support ENZC, one still needs to understand what needs to be resolved.
--
Hopefully these are addressed very quickly here by end of year or have some details out in the Short Trading Week this coming week. Charles C and team, have their own TIMELINE , which is complicated and has many parts that have to fit , before he moves forward on them. So just by watching the trends , I do not see this going current until 2021. Until that happens then many new investors , who will NOT , make a move until these catalyst formats are real and will continue to monitor. Until then there will be trading, flipping , and hopefully minimal conversion of any stock that is still out there.
--
** Items of Concern or need Action Steps taken, the rest of the areas of licensing , partner networking, Texas A and M , BTS research and on and on , will be forthcoming.
--
1. Obvious needs to go current. At least finish the Sept 2020 Filings , for Third Quarterly and get in the Attorney Letter to have an opportunity to make "Yield Sign" by end of year.
--
2. Any SEC Filing would be key , but none done since 4/16/2020. With the start of the year and the "Newly Amended" SEC accountability 15c-211, all OTC Market Symbols that are CE , SEC Delinquent, and that are not reporting information timely , can be looked at under a magnifying glass for potential issues action from the SEC. More to come , but many looking and watching any symbol that fits that category with concern.
--
3. Charles can come out and state the Control Block Transfer of Shares as described in the filing is Completed. This would be a Key as it would confirm "Change of Control" and worthy of an SEC FILING. We know that he has give the Bioclonetics Original investors options. Need to have this out by end of year and timeline. Thankfully there is at least one of the Original Investors here that have updated us . They have until Jan 2021 to make up their minds on what option to take, however I believe these shares are now in Charles's control or he would not have been able to offer them up, which is good.
https://backend.otcmarkets.com/otcapi/company/financial-report/265788/content
--
4. Very Large Item and concern still, was 'newly" disclosed on the last Filing, (Item 8). It shows the issuance of over "One Billion Shares" in two key TIME FRAMES. We know this due to the fact that from June to the Nov 30
Share Structure had increased then, in O/S and UnRestricted, so it is not new news, but the amounts and still to be determined who got them is not disclosed yet.
https://backend.otcmarkets.com/otcapi/company/financial-report/267170/content
-
Also as stated on the Business Combination disclosure , there were NEWLY CREATED SERIES B PREFERRED SHARES Issued to Charles and certain Bioclonetics designees, along with Harry Zhabilov. So the Share Structure after Nov. 30, 2020 , more than likely will go up in the A/S and O/S, Restricted areas once that is updated .
so note:
--
a. June 30, 2020 to Sept 30,2020
b. Sept 30,2020 to Nov 30, 2020
c. In this link (ITEM 8) Subsequent Events : it shows each issuance and the concern is , one does not know who,where, got them .
d. They show various price ranges at issuance.
e. It shows for a variety of reasons , claim purchase (someone buying debt which is what Livingston does, " for services" unknown, consulting services etc.
f. We knew they were issued (see below
++++
Quote from my earlier Post this Month
"Well take a look at the Disclosures folks
1. The TOXIC Lenders are all there getting millions of shares for DEBT CONVERSION , and that was for Hundreds of thousands of $$ dollars.
2. Then follow the Timeline
*
a. Year end 12/31/2019 Share Structure
A/S: 1.5 BILLION
O/S: 970 Million
Float : 327 Million
*
b. First Quarter March 31,2020 INCREASED
A/S: Still high around 1.4 Billion
O/S: 1.066 BILLION ...up 300 million
Float: 603 Million , yep that 300 million was converted
*
c. Second Quarter June 30, 2020 INCREASED
A/S: 3,000,000,000 , Yep 3 BILLION, (what is today as of 11/30/2020)
O/S 1.596 BILLION, another 500 million
Float: 857 Million
*
d. THIRD QUARTER (TBD not out yet) Sept 30, 2020 (see item 8 in June 30, quarter posting it describes amounts now)
*
e. NOW go to what it is at end of November 30 , 2020
A/S: 3 Billion (no change)
O/S: 2.75 Billion (Big change most probably done third Q 2020)
Float: 1.87 Billion (use Un restricted is closer +/-)
--------------
Summary
So this was all done during 2020 and you can see that much of that has already been converted from Toxic $$ DEBT (if not all) into Shares along the way .
The good thing as I said in my earlier post that over 1,100,000,000 BILLION (today 12.28 it is 1.5 billion shares) shares have traded since Thanksgiving alone and that means they are in stronger Hands.
Remember this from the PR end of October below
https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1721548
" As part of this initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agreed to a standstill on the issuance of any additional shares from conversions of debt.

TIME is an ILLUSION
---
TIMING is an actual ART

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News